Company Overview
About Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, activity, and manufacturability. Founded in 2021 and headquartered in Amsterdam with teams in San Francisco, Cradle raised approximately $24 million and targets biopharmaceutical, agricultural, and industrial biotechnology companies that need to engineer proteins with specific functional properties.
Business Model & Competitive Advantage
Cradle's platform combines large language models trained on protein sequence data (similar to how LLMs learn from text) with laboratory robotics integration to enable active learning workflows — the AI suggests protein variants to test, laboratory results are fed back to improve the model, and the cycle repeats until optimal variants are identified. This automated design-build-test cycle dramatically reduces the time and cost compared to traditional trial-and-error protein engineering.
Competitive Landscape 2025–2026
In 2025, Cradle competes in the AI-powered protein engineering market alongside Absci, EvolutionaryScale (ESM protein language model), and Generate Biomedicines for therapeutic applications, and with enzyme engineering companies like Codexis for industrial applications. The protein design AI space has accelerated significantly with AlphaFold 2's publication (structure prediction) and subsequent protein engineering tools. Cradle's focus on optimizing proteins for specific functional properties (rather than just predicting structure) addresses a critical need in drug development and industrial biotech. The 2025 strategy includes expanding platform coverage to antibody engineering and expanding enterprise deals with large biopharma companies for continuous protein optimization programs.
Recent Activity
View all →Key Differentiators
Strong Challenger
Cradle is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Compare Cradle with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cradle? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cradle Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cradle vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →